Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on May 19, 2025
Valley Fever Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
EIN Presswire
·
May 19, 2025
The Business Research Company’s Valley Fever Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 19, 2025 /EINPresswire.com/ -- The valley fever market has witnessed strong growth in …
Global Yeast Infection Treatment Market: Key Drivers, Trends, Growth Opportunities, And Forecast For 2025-2034
EIN Presswire
·
May 19, 2025
The Business Research Company's Yeast Infection Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 19, 2025 /EINPresswire.com/ -- The international market for yeast …
Global Post Operative Nausea And Vomiting Market To Reach $2.97 Billion By 2029 With A Growth Rate Of 7.4%
EIN Presswire
·
May 19, 2025
The Business Research Company's Post Operative Nausea And Vomiting Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 19, 2025 /EINPresswire.com/ -- The post-operative nausea and …
Polymyositis Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
EIN Presswire
·
May 19, 2025
The Business Research Company's Polymyositis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 19, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores …
Global Von Willebrand Disease Market Forecast 2025–2034: Growth Drivers, Market Share, Segments & Trends
EIN Presswire
·
May 19, 2025
The Business Research Company's Von Willebrand Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 19, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 19, 2025
Eyenovia and Betaliq continue to negotiate a binding merger agreement consistent with the previously announced signed Letter of Intent Reports continued progress on the development of the user-filled Optejet, and remains on track to file for U.S. device …
Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
GlobeNewswire
·
May 19, 2025
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC …
KabaFusion Acquires Infusion Care Assets from Coram® to Expand its Nationwide Footprint of Patient-Focused Services
GlobeNewswire
·
May 19, 2025
LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home and alternative site infusion, today announced it has closed on a transaction with Coram pursuant to which it has acquired 6 locations that will serve as …
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
May 19, 2025
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it will …
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 19, 2025
WELLESLEY HILLS, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the Company has granted an inducement …
Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference
GlobeNewswire
·
May 19, 2025
Company’s first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammation Novel bispecific design shows promising potential …
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
GlobeNewswire
·
May 19, 2025
-Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI) small interfering RNA (siRNA) for the treatment of thromboembolic disorders- -SRSD107 demonstrated peak …
Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and …
Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq
GlobeNewswire
·
May 19, 2025
DURHAM, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that Laura Niklason, M.D., …
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025
GlobeNewswire
·
May 19, 2025
IRVINE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, …
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 19, 2025
- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R…
ELISpot and FluoroSpot Assay Market CAGR 16.73 % with Growth USD 1504.67 Billion by 2033
EIN Presswire
·
May 19, 2025
Global ELISpot and FluoroSpot Assay market size is predicted to reach 1504.67 million by 2033 from USD 436.5 million in 2025, registering a CAGR of 16.73%. PUNE, MAHARASHTRA, INDIA, May 19, 2025 /EINPresswire.com/ -- "ELISpot and FluoroSpot Assay Market …
Life Sciences Analytics Market CAGR 7.23 % with Growth USD 39652.44 Billion by 2033
EIN Presswire
·
May 19, 2025
Life Sciences Analytics market size is anticipated to be worth USD 22685.04 M in 2025 and is expected to reach 39652.44 M by 2033 at a CAGR of 7.23%. PUNE, MAHARASHTRA, INDIA, May 19, 2025 /EINPresswire.com/ -- "Life Sciences Analytics Market" research …
Medical Electrodes Market CAGR 6.27 % with Growth USD 2632.35 Billion by 2033
EIN Presswire
·
May 19, 2025
Medical Electrodes market size in 2025 is estimated to be 1618.3 million, with projections to grow to 2632.35 million by 2033 at a CAGR of 6.27%. PUNE, MAHARASHTRA, INDIA, May 19, 2025 /EINPresswire.com/ -- "Medical Electrodes Market" research report …
Lysosomal Storage Disorders Market Set to Expand Across the 7MM During the Forecast Period (2025–2034) with Advances in Enzyme Replacement Therapies | DelveInsight
GlobeNewswire
·
May 19, 2025
New York, USA, May 19, 2025 (GLOBE NEWSWIRE) -- Lysosomal Storage Disorders Market Set to Expand Across the 7MM During the Forecast Period (2025–2034) with Advances in Enzyme Replacement Therapies | DelveInsight The lysosomal storage disorders market is …